Skip to main content

Evaluation of Purified Poloxamer 188 in Children in Crisis (EPIC): A Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial of MSY-188 injection in children with Sickle Cell disease experiencing vaso-occlusive crisis.

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Hematology

Awarded By

: Mast Therapeutics, Inc.

Start Date

May 1, 2014

End Date

April 30, 2017
 

Administered By

Medicine, Hematology

Awarded By

: Mast Therapeutics, Inc.

Start Date

May 1, 2014

End Date

April 30, 2017